A Study of Anticoagulation Treatment Patterns and Outcomes of Participants Hospitalized With Coronavirus Disease 2019 (COVID-19) in Japan

Bristol-Myers Squibb (BMS)

Status

Completed

Conditions

COVID-19

Study type

Observational

Funder types

Industry

Identifiers

NCT04828772

CV185-801

Details and patient eligibility

About

The purpose of this study is to describe demographic and clinical characteristics of participants who are hospitalized due to coronavirus 2019 (COVID-19), treatment use for COVID-19 and COVID-19 symptoms, and composite outcomes of COVID-19. This study will also compare composite outcomes between COVID-19 participants treated with and without anticoagulant therapy during follow-up period.

Enrollment

9,282 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

• At least one diagnosis code for COVID-19 (International Classification of Diseases (ICD)-10: U07.1 or B34.2) during hospitalization

Exclusion criteria

• None